Fidelis Capital Partners LLC acquired a new stake in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 49,943 shares of the company’s stock, valued at approximately $1,896,000.
Other hedge funds have also recently modified their holdings of the company. Ameriprise Financial Inc. boosted its position in shares of Columbia Research Enhanced Core ETF by 519.4% during the first quarter. Ameriprise Financial Inc. now owns 10,595,780 shares of the company’s stock worth $351,885,000 after acquiring an additional 8,885,095 shares during the last quarter. Raymond James Financial Inc. lifted its stake in Columbia Research Enhanced Core ETF by 73.6% in the 1st quarter. Raymond James Financial Inc. now owns 2,748,138 shares of the company’s stock worth $91,266,000 after purchasing an additional 1,164,853 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Columbia Research Enhanced Core ETF by 77.3% during the 2nd quarter. Commonwealth Equity Services LLC now owns 2,517,266 shares of the company’s stock valued at $92,610,000 after purchasing an additional 1,097,173 shares during the last quarter. Mason & Associates Inc purchased a new position in shares of Columbia Research Enhanced Core ETF during the second quarter valued at about $37,866,000. Finally, LPL Financial LLC grew its position in shares of Columbia Research Enhanced Core ETF by 11.0% during the first quarter. LPL Financial LLC now owns 8,987,115 shares of the company’s stock valued at $298,462,000 after purchasing an additional 893,397 shares in the last quarter.
Columbia Research Enhanced Core ETF Trading Up 0.2%
Shares of RECS stock opened at $40.34 on Monday. The stock has a market capitalization of $4.20 billion, a price-to-earnings ratio of 22.01 and a beta of 0.95. Columbia Research Enhanced Core ETF has a 12-month low of $28.64 and a 12-month high of $41.64. The stock’s 50-day moving average price is $40.06 and its 200-day moving average price is $37.63.
Columbia Research Enhanced Core ETF Company Profile
The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is managed by Columbia.
Recommended Stories
- Five stocks we like better than Columbia Research Enhanced Core ETF
- How to Profit From Value Investing
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Where to Find Earnings Call Transcripts
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding RECS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Core ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and related companies with MarketBeat.com's FREE daily email newsletter.
